Evidence map›Paper›PMID 40762187›Full record

ArticleJournal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology2025

Inverse Regulation of TLR4 and PD-L1 Shapes the Inflammatory Tumor Microenvironment in Oral Squamous Cell Carcinomas.

Camila Alves Ferri, Giuseppe Pannone, Maria Carmela Pedicillo, Giorgio Mori, Ilenia Sara De Stefano, Francesco Angelillis, Raffaele Barile, Roberta Seccia, Silvana Papagerakis, Angela Santoro and 12 more

Abstract readMulticenter Study
In one paragraph

Article in Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Inverse Regulation of TLR4 and PD-L1 Shapes the Inflammatory Tumor Microenvironment in Oral Squamous Cell Carcinomas.Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Camila Alves FerriOral Pathology and Oral Medicine Department, School of Dentistry, Universidade Federal Do Rio Grande Do Sul, Porto Alegre, Brazil.
Giuseppe PannoneDepartment of Clinical and Experimental Medicine, Pathological Anatomy Unit, University of Foggia, Foggia, Italy.
Maria Carmela PedicilloDepartment of Clinical and Experimental Medicine, Pathological Anatomy Unit, University of Foggia, Foggia, Italy.
Giorgio MoriDepartment of Clinical and Experimental Medicine, Pathological Anatomy Unit, University of Foggia, Foggia, Italy.
Ilenia Sara De StefanoDepartment of Clinical and Experimental Medicine, Pathological Anatomy Unit, University of Foggia, Foggia, Italy.
Francesco AngelillisDepartment of Clinical and Experimental Medicine, Pathological Anatomy Unit, University of Foggia, Foggia, Italy.
Raffaele BarileDepartment of Clinical and Experimental Medicine, Pathological Anatomy Unit, University of Foggia, Foggia, Italy.
Roberta SecciaDepartment of Clinical and Experimental Medicine, Pathological Anatomy Unit, University of Foggia, Foggia, Italy.
Silvana PapagerakisDepartment of ENT-Head and Neck Surgery, Faculty of Medicine, Université Laval, Quebec, Canada.
Angela SantoroDepartment of Sciences of the Women and Child Health, Operative Unit of Gynecological and Breast Pathology, Fondazione Policlinico Agostino Gemelli - UCSC, Rome, Italy.
Gian Franco ZannoniDepartment of Sciences of the Women and Child Health, Operative Unit of Gynecological and Breast Pathology, Fondazione Policlinico Agostino Gemelli - UCSC, Rome, Italy.
Gabriella AquinoDepartment of Pulmonary Oncology, AORN Dei Colli Monaldi, Naples, Italy.
Margherita CerronePathology Unit, Istituto Nazionale Tumori - INT- IRCCS - Fondazione G. Pascale, Napoli, Italy.
Monica CantilePathology Unit, Istituto Nazionale Tumori - INT- IRCCS - Fondazione G. Pascale, Napoli, Italy.
Vito RodolicoDepartment of Sciences for the Promotion of the Maternal and Childhood Health "G. D'alessandro", Section of Anatomic Pathology, University of Palermo, A.O.U. Policlinico "P. Giaccone", Palermo, Italy.ORCID https://orcid.org/0000-0003-1409-4207
Giuseppina CampisiDepartament of Surgical, Oncological and Oral Sciences, University of Palermo, Palermo, Italy.
Renato FrancoPathology Unit, Department of Mental and Physical Health and Preventive Medicine, University of Campania Luigi Vanvitelli, Naples, Italy.
Francesco MieleDepartment of Surgery, University of Campania Luigi Vanvitelli, Naples, Italy.
Rosanna ZampareseLegal Medicine Unit, Ascoli Piceno Hospital C-G, Ascoli Piceno, Italy.
Francesco LongoPathology Unit, Istituto Nazionale Tumori - INT- IRCCS - Fondazione G. Pascale, Napoli, Italy.
Lorenzo Lo MuzioDepartment of Clinical and Experimental Medicine, Oral Pathology Unit, University of Foggia, Foggia, Italy.ORCID https://orcid.org/0000-0003-4633-4893
Fernanda VisioliOral Pathology and Oral Medicine Department, School of Dentistry, Universidade Federal Do Rio Grande Do Sul, Porto Alegre, Brazil.ORCID https://orcid.org/0000-0002-4033-8431

Funding

CUP UNIFG D73C22001230006European Union - NextGenerationEU through the Ministry of University and Research as part of the PNRR Project M4C2-I1.3 PE_00000019
6 · The paper itself

Abstract

backgroundThe interactions between malignant cells and immune cells within the tumor microenvironment (TME) significantly influence cancer development and progression. This study aimed to analyze and correlate the expression of TLR4 and PD-L1 with the immune response, clinical characteristics, and prognosis of oral squamous cell carcinomas (OSCC).

methodsOur retrospective multicentric study consisted of the assessment of 166 OSCC specimens for TLR4, PD-L1, CD8, and Ki-67 expression in a TMA-based immunohistochemistry analysis.

resultsOur findings indicated an inverse correlation between the expression of PD-L1 and TLR4 (r = -0.348, p = 0.014, and r = -0.269, p = 0.049, superficial tumor site and in overall analysis, respectively). On the other hand, PD-L1 expression in the deep and superficial invasive front positively correlated with CD8+ T tumor infiltrating lymphocytes (TIL) in a statistically significant manner. A logistic regression analysis was performed to assess the impact of each variable on the clinical outcome with at least 5-year follow-up after the initial OSCC diagnosis. The multivariate model revealed that advanced T stage (T3-T4), presence of lymph node metastasis (N+), as well as performing chemotherapy were statistically significantly associated with OSCC mortality.

conclusionThese findings taken together suggest that there is a differential regulation of the immune response coordinated by activation of PD-L1 or TLR4 affecting T cell response.

Indexed as

B7-H1 AntigenCarcinoma, Squamous CellMouth NeoplasmsToll-Like Receptor 4Tumor MicroenvironmentAdultAgedAged, 80 and overCD8-Positive T-LymphocytesFemaleHumansImmunohistochemistryLymphocytes, Tumor-InfiltratingMaleMiddle AgedPrognosisB7-H1 AntigenCD274 protein, humanTLR4 protein, humanToll-Like Receptor 4CD8mortalityoral squamous cell carcinomaPD‐L1TLR4tumor infiltrating lymphocytes (TIL)tumor microenvironment

Identifiers

PMID40762187
PMCPMC12419984

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.